Rapidly Progressive Course of Primary Renal Synovial Sarcoma -Case Report
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INTRODUCTION
Primary renal synovial sarcoma (SS) is a rare tumor, first described by Faria et al in 1999 [1] . SS is a clinically, morphologically and genetically well defined entity. Although SS may occur at any unusual site, their predominant localization is in para-articular regions of the extremities in about 80% of cases. Since SS accounts for 5-10% of adult soft tissue sarcomas and primary renal sarcomas account for 1% of malignant renal tumors, it is quite clear why diagnosis of primary renal SS can be difficult [2, 3, 4] . Diagnostic dilemma of primary renal SS becomes evident because the growth is usually presented clinically as renal cell carcinoma and morphologically it is not simple to differentiate it from metastatic sarcoma, sarcomatoid renal cell carcinoma or other primary renal sarcomas. Fortunately, molecular pathological methods can solve diagnostic problems [5, 6] .
CASE REPORT
A 38-year-old man presented with a history of fever and hematuria, and right flank pain 3 weeks ago. On examination, a tender mass was palpable in his right flank. Abdominal computerized tomography (CT) revealed presence of heterogeneous, well-marginated mass arising in the lower part of the right kidney, sized 12×9 cm ( Figure 1A ). Abdominal MR imaging detected well circumscribed tumor, sized 120×85 mm, in the right kidney caudally, which was prominent to the perirenal retroperitoneal space, adherent to the psoas muscles without any infiltration of them. Tumor mass was non-homogenous and partially necrotic. Gerota's fascia was tended and edematous but not infiltrated. There was no intra abdominal lymphadenopathy or intra abdominal metastasis. According to the clinical and radiological presentation, laparotomy and radical right nephroureterectomy were performed. No extracapsular extension was noticed during operation.
On gross examination, a cystic tumor, measuring 120×90×85 mm, originated from the lower pole of the right kidney. Cut surface of greyish-white soft solid growth, with the extensive areas of hemorrhage and necrosis was seen (Figure 2 ). Histopathology revealed a neoplasm composed of solid cellular monomorphic sheets consisting of fascicles of spindle cells (Figure 3) , with the areas of necrosis and hemorrhage. Neovascularization was extensive and no epithelial differentiation was present. There was a moderate pleomorphism and mi- totic rate 8/10 high power magnification field. The tumor was relatively good margined from renal parenchyma and perirenal fat tissue. Immunohistochemistry showed tumor cells that were strongly positive for BCL2, CD99, CD56 and vimentin, and focally positive for epithelial membrane antigen (EMA) (Figure 4 ). They were negative for smooth muscle actin (SMA), CD10, desmin, CD34, TTF 1 , CK19. The histological diagnosis of primary monophasic SS of the kidney was based on morphology and immunohistochemistry. The patient was recommended by pathologist for chemiotherapy. Since the operator was not aware of the possibility that malignant cystic renal mass could be SS, the patient did not receive any therapy. In the meantime, the paraffin blocks were sent for molecular biological confirmation of PH diagnosis.
Fluorescence in situ hybridization (FISH) analysis was carried out on formalin-fixed paraffin-embedded tissue sections using the SS18 (18q11.2) Dual Colour BreakApart Probe (Abbott). Evidence of translocation involving the SS18 locus was detected ( Figure 5 ). The majority of nuclei displayed one set of fused signals and one set of split signals. A total of 500 nuclei from all areas of the tissue section were scored. Additionally, a reverse transcriptase polymerase chain reaction (RT-PCR) for SYT-SSX fusion gene transcripts using ribonucleic acid extracted from formalin-fixed paraffin-embedded tissue was performed using the primers given in Table 1 . The primer 'B-actin' (274 bp) was used as a 'housekeeping' primer to show good RNA quality. A number of control samples were used (RT-ve: No RNA template added to reverse transcription reaction; PCR-ve: No cDNA template added to PCR reaction; positive controls for both SSX1 and SSX 2 transcripts; negative control to ensure transcript specificity) to ensure sample specificity and rule out false positivity as a result of contamination. The RT-PCR revealed a translocation of SYT gene on chromosome 18 and SSX2 gene on chromosome X but lack of SS18-SSX1 translocation ( Figure 6 ). The findings were consistent with diagnosis of monophasic SS.
Two months later, when diagnosis was verified, CT scanning revealed traumatic worsening of the lesion. Diffuse spread of the tumor into retroperitoneal space on both sides was discovered ( Figure 1B) . The patient underwent second laparotomy. Grossly, by intraoperative observation, one could see an abundant widespread tumor mass infiltrating the retroperitoneal space on both sides and adhering to the vena cava inferior. Shortly afterwards, that is, three months after the first hospitalization, the patient died.
DISCUSSION
SS could be present in unexpected sites, such as thoracic and abdominal wall, head and neck region, retroperitoneum, as well as visceral organs such as lung, prostate and kidney [7, 8] . Previously, these tumors were diagnosed as embryonal sarcoma of the kidney or adult Wilms tumor but they subsequently revealed presence of the t(X;18) (p11.2:q11.2) translocation that is specific for SS [2] .
To the best of our knowledge, 64 cases of primary renal SS have been reported up to now upon reviewing 11 years of medical literature [9, 10, 11] . We presented here a young man at age of 38 years with primary renal SS. According to published data, our patient was a typical case. Clinical and imaging characteristics of this tumor were similar to other renal tumors, particularly to the renal cell carcinoma (RCC). Cystic formation which is very characteristic for SS, and was present in described patient's tumor, could be commonly seen in RCC, too. Clinical diagnosis is not possible [12, 13] .
SS may develop at unusual sites including kidney. Histologically, it is subclassified into biphasic SS, monophasic SS and poorly differentiated SS. According to the literature, the most common type of primary renal SS is monophasic, what was the case here [14] . The diagnosis based on morphological and immunomorphological tumor profile is also very difficult. Thus, our diagnosis of monophasic primary renal SS, based on morphology: plump spindle cells arranged in solid compact sheets without epithelial cell component, with abundant neovascularisation, and immunomorphology: BCL2, CD99, CD56, vimentin, and focally EMA positivity, was somehow daring [15, 16] . However, confirmation by genetic analysis took some time. Monophasic SS is often associated with the SS18-SSX2 translocation while biphasic SS is associated with the SS18-SSX1. In presented case, the SS18-SSX2 translocation was detected by FISH and RT-PCR techniques, and the diagnosis was verified [17, 18, 19] . Since primary renal SS is very rare neoplasm, no definite medical therapy has been established. Primary surgical resection of the tumor is positively the treatment of choice. However, as we could see in the present case, the prognosis is very poor when this treatment is alone. In principal, chemotherapy is recommended. Adjuvant therapy to radical nephrectomy mostly includes ifosfamide and doxorubicin. However, currently, there are no consistent data concerning the effect of chemotherapy on primary renal SS, which usually has aggressive behavior [20] .
In spite of diagnostic challenge for pathologists, in the presented case the histopathological diagnosis of primary renal SS was based on gross appearance of the cystic tumor, morphology and immunohistochemistry. However, it took a long time in our case to confirm the diagnosis of monophasic SS by molecular analysis, which revealed a translocation of SYT gene on chromosome 18 and SSX2 gene on chromosome X. Since the disease may have rapid course with bad outcome, as it was here, the clinicians need to be aware of the existence of this rare entity, so that timely and appropriate therapy can be applied.
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КРАТАК САДРЖАЈ Увод При мар ни сар ко ми бу бре га су ве о ма рет ки, а на ро-чи то си но ви јал ни сар ком (СС) бу бре га. Пре о пе ра ци о ни симп то ми су вр ло слич ни оста лим кар ци но ми ма бу бре га, те се пра ва ди јаг но за по ста вља тек по сле хи рур шког ле че-ња бо ле сни ка, тј. не фрек то ми је. Сле ди при каз бо ле сни ка с при мар ним СС бу бре га. При каз бо ле сни ка Три де се то смо го ди шњи му шка рац је око три не де ље имао нео д ре ђе не те го бе, ма лак са лост, по ви ше-ну тем пе ра ту ру, за те за ње у лум бал ном пре де лу и хе ма ту-ри ју. Ком пју те ри зо ва на то мо гра фи ја аб до ме на је по ка за ла хе те ро ге ну, ре ла тив но до бро огра ни че ну, де лом ци стич ну ту мор ску ма су на до њем по лу де сног бу бре га. Ура ђе на је не фрек то ми ја де сног бу бре га. Ма кро скоп ски је уочен ме-кот кив ни ту мор ци стич ног из гле да ве ли чи не 120×85 mm с оп се жним по љи ма не кро зе и кр ва ре ња. Хи сто па то ло шки на лаз је по ка зао да је реч о сар ко му ко ји чи не по ља из ра-же не нео ва ску ла ри за ци је са мо но морф ним фу зи форм ним ће ли ја ма. Иму но хи сто хе миј ски ту мор ске ће ли је су би ле стро го по зи тив не на BCL2, CD99, CD56 и ви мен тин, а фо кал-но по зи тив не на епи тел ни мем бран ски ан ти ген (EMA). На осно ву мор фо ло шке сли ке и иму но хи сто хе миј ске ана ли-зе ту мо ра по ста вље на је ди јаг но за при мар ног СС бу бре га. FISH ана ли за и RT-PCR су та ко ђе ура ђе ни на исеч ци ма тки ва фик си ра них у фор ма ли ну и ука лу пље них у па ра фи ну. Мо-ле ку лар не ана ли зе тки ва утвр ди ле су тран сло ка ци ју ге на SYT на хро мо зо му 18 и ге на SSX2 на хро мо зо му X. Ти ме је ди јаг но за СС бу бре га би ла по твр ђе на. За кљу чак Овај слу чај ја сно илу стру је да је хи сто па то ло-шка ди јаг но за при мар ног СС бу бре га, иако те шка, мо гу ћа на осно ву мор фо ло шких и иму но хи сто хе миј ских ана ли за. Ме ђу тим, ди јаг но за се мо ра по твр ди ти до ка зи ва њем тран-сло ка ци је ге на SYT и SSX на хро мо зо ми ма 18 и X мо ле ку лар-ним тех ни ка ма. Ов де је при ка зан мо но морф ни СС бу бре га агре сив ног то ка и бр зог смрт ног ис хо да. 
